13F Holdings
中文EN

DRMA Dermata Therapeutics, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1853816 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-7.4%
TTM EPS YoY-121.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-241.5%
ROA-162.3%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets41.1%
Debt / equity0.00x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.93x
Accruals ratio-10.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$2.93M$8.20M$4.07M$5.65M$3.46M
SG&A expense$4.84M$4.31M$3.97M$4.02M$4.40M
Operating income-$7.77M-$12.51M-$8.04M-$9.67M-$7.86M
Interest expense————$45,613
Income tax—$0$0$0$0
Net income-$7.56M-$12.29M-$7.79M-$9.61M-$7.90M
EBITDA————-$7.86M
EPS (basic)-8.16-80.32-39.99-13.92-2.43
EPS (diluted)-8.16-80.32-39.99——
Weighted avg. shares (diluted)926,192152,974194,928——
Banking
Net interest income———$63,573-$45,613
Balance sheet
Cash & equivalents$7.52M$3.16M$7.44M$6.24M$10.80M
Current assets$7.86M———$11.62M
PP&E, net————$0
Total assets$7.86M$3.53M$7.98M$6.94M$11.62M
Current liabilities————$1.52M
Short-term debt————$0
Total liabilities$1.64M$1.97M$1.62M$922,634$1.52M
Shareholders' equity$6.22M$1.56M$6.36M$6.02M$10.11M
Shares outstanding2.66M251,725261,998770,1158.33M
Cash flow statement
Operating cash flow-$7.76M-$11.16M-$6.41M-$8.83M-$5.69M
Financing cash flow$12.12M$6.89M$7.61M$4.28M$15.96M
Depreciation & amortization————$0
Stock-based compensation$143,732$657,649$522,082$930,325$1.91M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.